Study identifier:D133FR00204
ClinicalTrials.gov identifier:NCT06245837
EudraCT identifier:N/A
CTIS identifier:N/A
Multicenter, non-interventional, observational study of treatment and biomarker testing patterns, treatment outcomes in advanced/metastatic NSCLC with and without actionable genomic alterations in routine clinical practice in Russia
Non-small-cell lung cancer
N/A
No
-
All
1500
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|